Dedicated process development is at the heart of our work, and underlies the foundation for robust, standardized, and scalable cell and gene therapy (CGT) manufacturing solutions. Using our proven cell manufacturing platform, we have designed cell manufacturing processes used to process thousands of immune- and HSC-based gene therapy products. Take advantage of our extensive experience and let’s tailor your processes into lasting and robust solutions.
At any stage of your journey and at any level of experience, we can help you develop optimized CGT process workflows. Parallelized process design and development on the automated and closed CliniMACS Prodigy Platform and MACSQuant® Analyzer help to achieve a cost-efficient and scalable procedure that can serve as a common platform from research to clinical development and on to commercialization. An iterative process of optimization, material generation, and characterization culminate in a refined manufacturing process to meet the requirements for IND filing.
We generate the necessary documents and reports for seamless industrialization: